Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Temporal changes in avian community composition in lowland conifer habitats at the southern edge of the boreal zone in the Adirondack Park, NY.

Glennon MJ, Langdon SF, Rubenstein MA, Cross MS.

PLoS One. 2019 Aug 19;14(8):e0220927. doi: 10.1371/journal.pone.0220927. eCollection 2019.

2.

Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells.

Bozdag M, Ferraroni M, Ward C, Carta F, Bua S, Angeli A, Langdon SP, Kunkler IH, Al-Tamimi AS, Supuran CT.

Eur J Med Chem. 2019 Aug 7;182:111600. doi: 10.1016/j.ejmech.2019.111600. [Epub ahead of print]

PMID:
31419777
3.

Interlaboratory study to validate a STR profiling method for intraspecies identification of mouse cell lines.

Almeida JL, Dakic A, Kindig K, Kone M, Letham DLD, Langdon S, Peat R, Holding-Pillai J, Hall EM, Ladd M, Shaffer MD, Berg H, Li J, Wigger G, Lund S, Steffen CR, Fransway BB, Geraghty B, Natoli M, Bauer B, Gollin SM, Lewis DW, Reid Y.

PLoS One. 2019 Jun 20;14(6):e0218412. doi: 10.1371/journal.pone.0218412. eCollection 2019.

4.

On Neuropsychiatric Manifestations of Basal Ganglia Injury: A Report of Three Cases and Literature Review.

Azizi H, Kilpatrick A, Olayinka O, Poopola O, Ahmad M, Kahn A, Khan T, Rimawi D, Williams S, Jayaraj S, Leung I, Langdon S, Iskander M, Chohan A, Nuthalapati D, Umesi U, Vyas G, Oyelakin A, Kodjo K, Ojimba C, Jegede O, Nisenoff C, Jolayemi A.

Case Rep Neurol Med. 2019 Apr 4;2019:3298791. doi: 10.1155/2019/3298791. eCollection 2019.

5.

Neuropsychiatric Manifestations of Partial Agenesis of the Corpus Callosum: A Case Report and Literature Review.

Popoola O, Olayinka O, Azizi H, Ojimba C, Khan T, Kallikkadan J, Ahmad M, Jay J, Canale C, Langdon S, Kahn A, Nuthalapati D, Jayaraj S, Mahbub A, Olaolu O, Kodjo K, Olupona T, Nisenoff C, Jolayemi A.

Case Rep Psychiatry. 2019 Mar 25;2019:5925191. doi: 10.1155/2019/5925191. eCollection 2019.

6.

Development and characterisation of acquired radioresistant breast cancer cell lines.

Gray M, Turnbull AK, Ward C, Meehan J, Martínez-Pérez C, Bonello M, Pang LY, Langdon SP, Kunkler IH, Murray A, Argyle D.

Radiat Oncol. 2019 Apr 15;14(1):64. doi: 10.1186/s13014-019-1268-2.

7.

Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and Treatment.

Ward C, Meehan J, Gray M, Kunkler IH, Langdon SP, Murray A, Argyle D.

Curr Top Microbiol Immunol. 2019 Mar 12. doi: 10.1007/82_2019_159. [Epub ahead of print]

PMID:
30859401
8.

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer.

Bonello M, Sims AH, Langdon SP.

Cancer Biol Med. 2018 Nov;15(4):375-388. doi: 10.20892/j.issn.2095-3941.2018.0062.

9.

Fish Oil Supplementation in Overweight/Obese Patients with Uncontrolled Asthma. A Randomized Trial.

Lang JE, Mougey EB, Hossain MJ, Livingston F, Balagopal PB, Langdon S, Lima JJ.

Ann Am Thorac Soc. 2019 May;16(5):554-562. doi: 10.1513/AnnalsATS.201807-446OC.

PMID:
30678465
10.

HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.

Jarman EJ, Ward C, Turnbull AK, Martinez-Perez C, Meehan J, Xintaropoulou C, Sims AH, Langdon SP.

Breast Cancer Res. 2019 Jan 22;21(1):10. doi: 10.1186/s13058-019-1097-0.

11.

PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity.

Carnevalli LS, Sinclair C, Taylor MA, Gutierrez PM, Langdon S, Coenen-Stass AML, Mooney L, Hughes A, Jarvis L, Staniszewska A, Crafter C, Sidders B, Hardaker E, Hudson K, Barry ST.

J Immunother Cancer. 2018 Dec 27;6(1):158. doi: 10.1186/s40425-018-0457-0.

12.

Biocompatibility of common implantable sensor materials in a tumor xenograft model.

Gray ME, Meehan J, Blair EO, Ward C, Langdon SP, Morrison LR, Marland JRK, Tsiamis A, Kunkler IH, Murray A, Argyle D.

J Biomed Mater Res B Appl Biomater. 2019 Jul;107(5):1620-1633. doi: 10.1002/jbm.b.34254. Epub 2018 Oct 27.

13.

Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity.

Langdon S, Hughes A, Taylor MA, Kuczynski EA, Mele DA, Delpuech O, Jarvis L, Staniszewska A, Cosulich S, Carnevalli LS, Sinclair C.

Oncoimmunology. 2018 May 7;7(8):e1458810. doi: 10.1080/2162402X.2018.1458810. eCollection 2018.

14.

Implantable biosensors and their contribution to the future of precision medicine.

Gray M, Meehan J, Ward C, Langdon SP, Kunkler IH, Murray A, Argyle D.

Vet J. 2018 Sep;239:21-29. doi: 10.1016/j.tvjl.2018.07.011. Epub 2018 Jul 29. Review.

15.

Predictive markers of endocrine response in breast cancer.

Mosly D, Turnbull A, Sims A, Ward C, Langdon S.

World J Exp Med. 2018 Aug 30;8(1):1-7. doi: 10.5493/wjem.v8.i1.1. eCollection 2018 Aug 30.

16.

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.

Xintaropoulou C, Ward C, Wise A, Queckborner S, Turnbull A, Michie CO, Williams ARW, Rye T, Gourley C, Langdon SP.

BMC Cancer. 2018 Jun 5;18(1):636. doi: 10.1186/s12885-018-4521-4.

17.

Two sides of the same coin: Monetary incentives concurrently improve and bias confidence judgments.

Lebreton M, Langdon S, Slieker MJ, Nooitgedacht JS, Goudriaan AE, Denys D, van Holst RJ, Luigjes J.

Sci Adv. 2018 May 30;4(5):eaaq0668. doi: 10.1126/sciadv.aaq0668. eCollection 2018 May.

18.

Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.

Ward C, Meehan J, Gray M, Kunkler IH, Langdon SP, Argyle DJ.

Metabolites. 2018 Feb 10;8(1). pii: E13. doi: 10.3390/metabo8010013. Review.

19.

NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib.

Kankia IH, Khalil HS, Langdon SP, Moult PR, Bown JL, Deeni YY.

Oxid Med Cell Longev. 2017;2017:1864578. doi: 10.1155/2017/1864578. Epub 2017 Dec 19.

20.

Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.

Meehan J, Ward C, Turnbull A, Bukowski-Wills J, Finch AJ, Jarman EJ, Xintaropoulou C, Martinez-Perez C, Gray M, Pearson M, Mullen P, Supuran CT, Carta F, Harrison DJ, Kunkler IH, Langdon SP.

Oncotarget. 2017 Jun 27;8(26):42857-42875. doi: 10.18632/oncotarget.17143.

21.

Overlap Extension Barcoding for the Next Generation Sequencing and Genotyping of Plasmodium falciparum in Individual Patients in Western Kenya.

Levitt B, Obala A, Langdon S, Corcoran D, O'Meara WP, Taylor SM.

Sci Rep. 2017 Jan 24;7:41108. doi: 10.1038/srep41108.

22.

Endocrine therapy in epithelial ovarian cancer.

Langdon SP, Gourley C, Gabra H, Stanley B.

Expert Rev Anticancer Ther. 2017 Feb;17(2):109-117. doi: 10.1080/14737140.2017.1272414. Epub 2016 Dec 24. Review.

23.

Kinetic modelling of in vitro data of PI3K, mTOR1, PTEN enzymes and on-target inhibitors Rapamycin, BEZ235, and LY294002.

Goltsov A, Tashkandi G, Langdon SP, Harrison DJ, Bown JL.

Eur J Pharm Sci. 2017 Jan 15;97:170-181. doi: 10.1016/j.ejps.2016.11.008. Epub 2016 Nov 8.

24.

A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells.

Khalil HS, Langdon SP, Goltsov A, Soininen T, Harrison DJ, Bown J, Deeni YY.

Oncotarget. 2016 Nov 15;7(46):75874-75901. doi: 10.18632/oncotarget.12425.

25.

Community Health Asset Mapping Partnership Engages Hispanic/Latino Health Seekers and Providers.

Cutts T, Langdon S, Meza FR, Hochwalt B, Pichardo-Geisinger R, Sowell B, Chapman J, Dorton LB, Kennett B, Jones MT.

N C Med J. 2016 May-Jun;77(3):160-7. doi: 10.18043/ncm.77.3.160.

26.

Contemporary outcomes after pericardial window surgery: impact of operative technique.

Langdon SE, Seery K, Kulik A.

J Cardiothorac Surg. 2016 Apr 26;11(1):73. doi: 10.1186/s13019-016-0466-3.

27.

Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models.

Martínez-Pérez C, Ward C, Turnbull AK, Mullen P, Cook G, Meehan J, Jarman EJ, Thomson PI, Campbell CJ, McPhail D, Harrison DJ, Langdon SP.

Br J Cancer. 2016 Apr 12;114(8):905-16. doi: 10.1038/bjc.2016.6. Epub 2016 Mar 31.

28.

Lessons Learned From a Community-Based Participatory Research Mental Health Promotion Program for American Indian Youth.

Langdon SE, Golden SL, Arnold EM, Maynor RF, Bryant A, Freeman VK, Bell RA.

Health Promot Pract. 2016 May;17(3):457-63. doi: 10.1177/1524839916636568. Epub 2016 Mar 23.

PMID:
27009131
29.

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models.

Koussounadis A, Langdon SP, Um I, Kay C, Francis KE, Harrison DJ, Smith VA.

BMC Cancer. 2016 Mar 10;16:205. doi: 10.1186/s12885-016-2212-6.

30.

NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies.

Khalil HS, Langdon SP, Kankia IH, Bown J, Deeni YY.

Oxid Med Cell Longev. 2016;2016:4148791. doi: 10.1155/2016/4148791. Epub 2015 Dec 7.

31.

The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer.

Huang R, Langdon SP, Tse M, Mullen P, Um IH, Faratian D, Harrison DJ.

Oncotarget. 2016 Jan 26;7(4):4695-711. doi: 10.18632/oncotarget.6618.

32.

Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers.

Briffa R, Um I, Faratian D, Zhou Y, Turnbull AK, Langdon SP, Harrison DJ.

PLoS One. 2015 Dec 17;10(12):e0144708. doi: 10.1371/journal.pone.0144708. eCollection 2015.

33.

Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy.

Li YW, Seager MA, Wojcik T, Heman K, Molski TF, Fernandes A, Langdon S, Pendri A, Gerritz S, Tian Y, Hong Y, Gallagher L, Merritt JR, Zhang C, Westphal R, Zaczek R, Macor JE, Bronson JJ, Lodge NJ.

Neuropharmacology. 2016 Mar;102:121-35. doi: 10.1016/j.neuropharm.2015.10.037. Epub 2015 Oct 30.

PMID:
26522433
34.

Novel Monte Carlo approach quantifies data assemblage utility and reveals power of integrating molecular and clinical information for cancer prognosis.

Verleyen W, Langdon SP, Faratian D, Harrison DJ, Smith VA.

Sci Rep. 2015 Oct 27;5:15563. doi: 10.1038/srep15563.

35.

Technical innovation in adjuvant radiotherapy: Evolution and evaluation of new treatments for today and tomorrow.

Kunkler IH, Ward C, Langdon SP.

Breast. 2015 Nov;24 Suppl 2:S114-9. doi: 10.1016/j.breast.2015.07.026. Epub 2015 Oct 1. Review.

PMID:
26429399
36.

A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models.

Xintaropoulou C, Ward C, Wise A, Marston H, Turnbull A, Langdon SP.

Oncotarget. 2015 Sep 22;6(28):25677-95. doi: 10.18632/oncotarget.4499.

37.

Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.

Ward C, Meehan J, Mullen P, Supuran C, Dixon JM, Thomas JS, Winum JY, Lambin P, Dubois L, Pavathaneni NK, Jarman EJ, Renshaw L, Um IH, Kay C, Harrison DJ, Kunkler IH, Langdon SP.

Oncotarget. 2015 Sep 22;6(28):24856-70. doi: 10.18632/oncotarget.4498.

38.

Rationale and Design of the Echocardiographic Study of Hispanics/Latinos (ECHO-SOL).

Rodriguez CJ, Dharod A, Allison MA, Shah SJ, Hurwitz B, Bangdiwala SI, Gonzalez F, Kitzman D, Gillam L, Spevack D, Dadhania R, Langdon S, Kaplan R.

Ethn Dis. 2015 Spring;25(2):180-6.

39.

Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system.

Koussounadis A, Langdon SP, Um IH, Harrison DJ, Smith VA.

Sci Rep. 2015 Jun 8;5:10775. doi: 10.1038/srep10775.

40.

Origin of chemoselectivity in N-heterocyclic carbene catalyzed cross-benzoin reactions: DFT and experimental insights.

Langdon SM, Legault CY, Gravel M.

J Org Chem. 2015 Apr 3;80(7):3597-610. doi: 10.1021/acs.joc.5b00301. Epub 2015 Mar 18.

PMID:
25734574
41.

Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cells.

Khalil HS, Goltsov A, Langdon SP, Harrison DJ, Bown J, Deeni Y.

J Biotechnol. 2015 May 20;202:12-30. doi: 10.1016/j.jbiotec.2014.09.027. Epub 2014 Nov 5.

PMID:
25449014
42.

Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.

Pettersen EO, Ebbesen P, Gieling RG, Williams KJ, Dubois L, Lambin P, Ward C, Meehan J, Kunkler IH, Langdon SP, Ree AH, Flatmark K, Lyng H, Calzada MJ, Peso LD, Landazuri MO, Görlach A, Flamm H, Kieninger J, Urban G, Weltin A, Singleton DC, Haider S, Buffa FM, Harris AL, Scozzafava A, Supuran CT, Moser I, Jobst G, Busk M, Toustrup K, Overgaard J, Alsner J, Pouyssegur J, Chiche J, Mazure N, Marchiq I, Parks S, Ahmed A, Ashcroft M, Pastorekova S, Cao Y, Rouschop KM, Wouters BG, Koritzinsky M, Mujcic H, Cojocari D.

J Enzyme Inhib Med Chem. 2015;30(5):689-721. doi: 10.3109/14756366.2014.966704. Epub 2014 Oct 27. Review.

PMID:
25347767
43.

Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancer.

Martinez-Perez C, Ward C, Cook G, Mullen P, McPhail D, Harrison DJ, Langdon SP.

Biochem Soc Trans. 2014 Aug;42(4):1017-23. doi: 10.1042/BST20140073. Review.

PMID:
25109996
44.

Systems analysis of drug-induced receptor tyrosine kinase reprogramming following targeted mono- and combination anti-cancer therapy.

Goltsov A, Deeni Y, Khalil HS, Soininen T, Kyriakidis S, Hu H, Langdon SP, Harrison DJ, Bown J.

Cells. 2014 Jun 10;3(2):563-91. doi: 10.3390/cells3020563.

45.

Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer.

Koussounadis A, Langdon SP, Harrison DJ, Smith VA.

Br J Cancer. 2014 Jun 10;110(12):2975-84. doi: 10.1038/bjc.2014.258. Epub 2014 May 27.

46.

Monoamine reuptake site occupancy of sibutramine: Relationship to antidepressant-like and thermogenic effects in rats.

Li YW, Langdon S, Pieschl R, Strong T, Wright RN, Rohrbach K, Lelas S, Lodge NJ.

Eur J Pharmacol. 2014 Aug 15;737:47-56. doi: 10.1016/j.ejphar.2014.03.024. Epub 2014 May 10.

PMID:
24821570
47.

Chemoselective N-heterocyclic carbene-catalyzed cross-benzoin reactions: importance of the fused ring in triazolium salts.

Langdon SM, Wilde MM, Thai K, Gravel M.

J Am Chem Soc. 2014 May 28;136(21):7539-42. doi: 10.1021/ja501772m. Epub 2014 May 16.

PMID:
24809936
48.

Perceptions and psychosocial correlates of bullying among Lumbee Indian youth.

Bell R, Arnold E, Golden S, Langdon S, Anderson A, Bryant A.

Am Indian Alsk Native Ment Health Res. 2014;21(1):1-17. doi: 10.5820/aian.2101.2014.1.

49.

Increased STAT1 signaling in endocrine-resistant breast cancer.

Huang R, Faratian D, Sims AH, Wilson D, Thomas JS, Harrison DJ, Langdon SP.

PLoS One. 2014 Apr 11;9(4):e94226. doi: 10.1371/journal.pone.0094226. eCollection 2014.

50.

Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinations.

Goltsov A, Langdon SP, Goltsov G, Harrison DJ, Bown J.

Front Oncol. 2014 Feb 5;4:13. doi: 10.3389/fonc.2014.00013. eCollection 2014.

Supplemental Content

Loading ...
Support Center